Literature DB >> 949879

Reduction of pleural fluid complement activity in patients with systemic lupus erythematosus and rheumatoid arthritis.

M M Glovsky, J S Louie, W H Pitts, A Alenty.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 949879     DOI： 10.1016/0090-1229(76)90057-x

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN： 0090-1229


× No keyword cloud information.
  4 in total

Review 1.  Pulmonary manifestations of the rheumatic diseases.

Authors:  D W Boulware; D N Weissman; N J Doll
Journal:  Clin Rev Allergy       Date:  1985-05

2.  Refractory massive pleural effusion in systemic lupus erythematosus treated with talc poudrage.

Authors:  J L Kaine
Journal:  Ann Rheum Dis       Date:  1985-01       Impact factor: 19.103

3.  Chemical and immunological features of pleural effusions: comparison between rheumatoid arthritis and other diseases.

Authors:  T Pettersson; M Klockars; P E Hellström
Journal:  Thorax       Date:  1982-05       Impact factor: 9.139

4.  ANA positivity and complement level in pleural fluid are potential diagnostic markers in discriminating lupus pleuritis from pleural effusion of other aetiologies.

Authors:  Der-Yuan Chen; Yen-Hsiang Huang; Yi-Ming Chen; Jeremy J W Chen; Tsung-Ying Yang; Gee-Chen Chang; Kuo-Tung Tang
Journal:  Lupus Sci Med       Date:  2021-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.